Aalberts reports the progress of its share buyback programme 14 April – 17 April 2025 Utrecht, 22 April 2025 Aalberts today reports that it has repurchased 220,693 of its own shares in the period from 14 April 2025, up to and including 17 April 2025, for an amount of EUR 5,934,725.28, so at an average share price of EUR 26.89. This is part of the share buyback programme as announced on 27 February 2025, for a total amount of EUR 75 million. The repurchase of shares commenced on 28 February 2025 and will be completed no later than 24 October 2025. It is intended that the shares will be ca...
Aalberts: Preview - priced like it is 2009 all over again. ABN AMRO: Pre-close 1Q – focus on capital & new CEO. Ahold Delhaize: Preview 1Q25. Arcadis: Gatwick work. Basic-Fit: 1Q25 trading update; strong membership ingrowth; CB repayment refinancing. CM.com: 1Q25 trading update. Fastned: 1Q25 trading update; disappointing charging volumes. NSI: A steady quarter, increasing vacancy on the horizon. Sligro: Soft 1Q25 sales, no outlook provided. Wereldhave: Guidance at the higher e...
Aalberts reports the progress of its share buyback programme 07 April – 11 April 2025 Utrecht, 15 April 2025 Aalberts today reports that it has repurchased 366,000 of its own shares in the period from 07 April 2025, up to and including 11 April 2025, for an amount of EUR 9,809,962, so at an average share price of EUR 26.80. This is part of the share buyback programme as announced on 27 February 2025, for a total amount of EUR 75 million. The repurchase of shares commenced on 28 February 2025 and will be completed no later than 24 October 2025. It is intended that the shares will be cance...
Trumps reciprocal tariffs caused a massive blow to equity markets, following a pressured period of escalating trade wars. Retaliatory measures can further heavily damage market confidence, as seen Friday when China announced their 34% tarrif of US goods. International trade policies have never moved this erratic and untransparant, with uncertainty and volatility being the baseline for now. In this report we highlight the key stocks in our coverage relevant to this discussion.
Aalberts reports the progress of its share buyback programme 31 March – 04 April 2025 Utrecht 8 April, Aalberts today reports that it has repurchased 324,632 of its own shares in the period from 31 March 2025, up to and including 04 April 2025, for an amount of EUR 9,719,758, so at an average share price of EUR 29.94. This is part of the share buyback programme as announced on 27 February 2025, for a total amount of EUR 75 million. The repurchase of shares commenced on 28 February 2025 and will be completed no later than 24 October 2025. It is intended that the shares will be cancelled f...
Aalberts reports the progress of its share buyback programme 24 – 28 March 2025 Utrecht, 1 April 2025 Aalberts today reports that it has repurchased 206,486 of its own shares in the period from 24 March 2025, up to and including 28 March 2025, for an amount of EUR 6,780,265, so at an average share price of EUR 32.84. This is part of the share buyback programme as announced on 27 February 2025, for a total amount of EUR 75 million. The repurchase of shares commenced on 28 February 2025 and will be completed no later than 24 October 2025. It is intended that the shares will be cancelled fo...
Aalberts reports the progress of its share buyback programme 17 – 21 March 2025 Aalberts today reports that it has repurchased 146,500 of its own shares in the period from 17 March 2025, up to and including 21 March 2025, for an amount of EUR 4,970,798, so at an average share price of EUR 33.93. This is part of the share buyback programme as announced on 27 February 2025, for a total amount of EUR 75 million. The repurchase of shares commenced on 28 February 2025 and will be completed no later than 24 October 2025. It is intended that the shares will be cancelled following repurchase. Up...
GREATER CHINA Results COSCO SHIPPING Ports (1199 HK/BUY/HK$4.78/Target: HK$5.90) 2024: Core earnings in line; expect low single digit throughput growth in 2025. CSPC Innovation Pharmaceutical Co (300765 CH/BUY/Rmb37.00/Target: Rmb50.00) 2024: Smooth progress in R&D promises bright long-term outlook. Hansoh Pharmaceutical Group Company (3692 HK/BUY/HK$20.10/Target:HK$29.00) 2024: Results beat; strong growth momentum continues. Meituan (3690 HK/BUY/HK$167.60/Target: HK$216.00) ...
Aalberts reports the progress of its share buyback programme 10 – 14 March 2025 Utrecht, 18 March 2025 Aalberts today reports that it has repurchased 144,030 of its own shares in the period from 10 March 2025, up to and including 14 March 2025, for an amount of EUR 4,901,346, so at an average share price of EUR 34.03 This is part of the share buyback programme as announced on 27 February 2025, for a total amount of EUR 75 million. The repurchase of shares commenced on 28 February 2025 and will be completed no later than 24 October 2025. It is intended that the shares will be cancelled fol...
Aalberts reports the progress of its share buyback programme 28 February – 7 March 2025 Aalberts today reports that it has repurchased 130,162 of its own shares in the period from 28 February 2025, up to and including 7 March 2025, for an amount of EUR 4,280,824, so at an average share price of EUR 32.89. This is part of the share buyback programme as announced on 27 February 2025, for a total amount of EUR 75 million. The repurchase of shares commenced on 28 February 2025 and will be completed no later than 24 October 2025. It is intended that the shares will be cancelled following repurc...
Two Directors at Aalberts NV bought 8,000 shares at between 32.320EUR and 32.460EUR. The significance rating of the trade was 60/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the las...
We briefly summarised main key take-aways of the FY24 analyst call of Aalberts. We point out there were quite some technical issues during the presentation. Overall tone in our view is that visibility remains very low as usual but this now also applies to Semicon which in the past was labelled as having good visibility linked to its order book. Margins in Industry were impressive in spite of the steep organic revenue drop.
Aalberts: Dividend and outlook better than expected. Ackermans & van Haaren: Anticipating an all-time-high result from core segments. Ageas: FY24 in line, strong capital, outlook for upsteams. AMG: Strong 4Q24 beat and 2025F guidance upgrade. CFE: Solid results and balance sheet, outlook weak. CMB.TECH: Cautious on outlook. Corbion: Not so sweet. CTP: Good results, 2025 outlook realistic. D'Ieteren: Boyd's Five-Year Goals. Exor: Ferrari €3bn ABB and €1bn SBB. Sofina: Further ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.